Table 1.
Exon/primer | Sequence, dye, and quencher∗ |
---|---|
TNXB exon 35 | |
Forward | 5′-GAGCCTCAGAGTGTGCAGGT-3′ |
Reverse | 5′-GTTTTCTTGgCTCCCAcctc-3′ |
Probe | 5′-FAM-ctgggatcagccCCTGGAGT-MGB-3′ |
TNXB exon 40 | |
Forward | 5′-TCCTCAACGGCAACCGc-3′ |
Reverse | 5′-GAACACCTGGGAAGCAAGTG-3′ |
Probe | 5′-FAM-CGTGTTTTGcGACATGGAGAC-MGB-3′ |
HBB | |
Forward | 5′-TATCATGCCTCTTTGCACCA-3′ |
Reverse | 5′-AATCCAGCCTTATCCCAACC-3′ |
Probe3 | 5′-VIC-CAGCTACAATCCAGCTACCATTCTGC-MGB-3′ |
CAH-X, connective tissue dysplasia consistent with hypermobility-type Ehlers-Danlos syndrome due to a contiguous gene deletion involving the adjacent CYP21A2 and TNXB genes.
DNA bases specific to the active gene TNXB are marked in lowercase, and bases shared by both TNXB and pseudogene TNXA are shown in capitals.